Proinflammatory cytokines are not released in the circulation following acute pulmonary thromboembolism in pigs

Journal of Investigative Surgery

Volumn 15, Issue 1, 2002, Pages 29-35

  Tsang, John ^a   Simon, Mathieu ^a,b,c   Stewart, Ken ^a   Qayumi, Karim ^a   Battistini, Bruno ^b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

Acute lung injury; Clot; Cytokines; Inflammation; Pulmonary embolism

Indexed keywords

CYTOKINE; ENDOTHELIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; SODIUM CHLORIDE; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUID THERAPY; GAS EXCHANGE; HEART OUTPUT; LUNG ARTERY PRESSURE; LUNG CIRCULATION; LUNG EMBOLISM; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SWINE; SYSTEMIC CIRCULATION;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMODYNAMIC PROCESSES; INTERLEUKIN-1; INTERLEUKIN-8; PULMONARY EMBOLISM; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036204843     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.1080/08941930252807769     Document Type: Article

References (34)

1. Acute lung injury: The role of cytokines in the elicitation of neutrophils
2. Circulating interleukin 1 and tumor necrosis factor in septic shock and experimental endotoxin fever
3. Plasma cytokine and endotoxin levels correlate with survival in patients with sepsis syndrome
4. The pulmonary, vascular lesion of the adult respiratory distress syndrome
5. Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock
6. Hypoxemia in acute pulmonary embolism
7. The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism
8. 2 to the acute cardiopulmonary changes of pulmonary embolism
9. Pathophysiology and treatments of haemodynamic instability in acute pulmonary embolism: The pivotal role of pulmonary vasoconstriction
10. Hypoxemia in pulmonary embolism, a clinical study
11. Time course of pulmonary vascular response to micro-embolization
12. Therapeutic benefits of 5-hydroxytryptamine inhibition following pulmonary embolism
13. Bronchoalveolar lavage alterations in pulmonary embolism
14. The involvement of prostaglandins and thromboxane in the response to pulmonary embolism in anesthetized rabbits and isolated perfused lungs
15. Endothelin abnormalities in patients with pulmonary embolism
16. Acute respiratory distress syndrome: Pathogenesis
17. Tumor necrosis factor: An updated review of its biology
18. Tumor necrosis factors receptor associated signalling molecules and their roles in activation of apoptosis, JNK and NF-kappaB
19. IL-1 ra suppresses endotoxin-induced IL-1 beta and TNF-alpha release from mononuclear phagocytes
20. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody
21. Acute lung injury and the acute respiratory distress syndrome
22. Role of interleukin-8 in neutrophil signaling
23. Mechanisms of lung vascular injury and edema after pulmonary microembolism
24. Combination of IL-8 plus TNF alpha induces additive neutrophil migration
25. Interleukin-1 induces a shock-like state in rabbits Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition
26. Pathogenesis strategies for prevention and treatment of septic shock
27. Detection of circulating tumor necrosis after endotoxin administration
28. Dissociation between plasma and monocyte-associated cytokines during sepsis
29. Sequential release of TNF, PAF and eicosanoids during endotoxin shock in anesthetized pigs; Protective effects of indomethacin
30. Prostacycline and thromboxane A2 formation is increased in human sepsis syndrome
31. Balance of inflammatory cytokines related to severity and mortality of murine sepsis
32. Increased soluble interleukin-1 type. II receptor concentrations in post-operative patients and in patients with sepsis syndrome
33. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients
34. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients